CHICAGO--(BUSINESS WIRE)--Cardio Diagnostics Holdings, Inc. (Nasdaq: CDIO), a leader in artificial intelligence-driven precision cardiovascular medicine tests, and Family Medicine Specialists (FMS), a ...
CHICAGO--(BUSINESS WIRE)--Cardio Diagnostics, Inc, a biotechnology company making cardiovascular disease prevention and early detection more accessible, personalized and precise, announces the launch ...
Cardio Diagnostics Holdings Inc. (NASDAQ:CDIO), an AI-powered precision cardiovascular medicine company, is making progress in gaining broad access to Medicare reimbursement for its Epi+Gen CHD™ and ...
Coronary heart disease ("CHD") remains the leading cause of death in the United States, but the tools doctors have long relied on to detect it early are proving less reliable than many patients ...
CHICAGO--(BUSINESS WIRE)-- Cardio Diagnostics Holdings Inc (Nasdaq: CDIO), an artificial intelligence-powered precision cardiovascular medicine company, today announced the launch of PrecisionCHD™, an ...
Cardio Diagnostics’ AI-driven coronary heart disease (CHD) tests have taken another promising step in their evolution. Cardio Diagnostics CDIO, an artificial intelligence-powered precision ...
From young people dying suddenly of heart attacks to a 50% surge in cardiac medication sales in India over the past five years, cardiovascular disease (CVD) is clearly on the rise. Cardiovascular ...
Add Yahoo as a preferred source to see more of our stories on Google. A single blood test that measures inflammation and fat can predict women's risk for cardiovascular disease 30 years later, a new ...
Mike Conner and Alex Jesko explain how firefighters can recognize cardiovascular risk early, act on abnormal findings and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results